RPAM
CLVS
Rhenman & Partners Asset Management’s Clovis Oncology, Inc. CLVS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q1 | – | Sell |
-73,000
| Closed | -$2.56M | – | 98 |
|
|
2015
Q4 | $2.56M | Buy |
73,000
+30,000
| +70% | +$1.05M | 0.39% | 77 |
|
|
2015
Q3 | $3.95M | Sell |
43,000
-17,765
| -29% | -$1.63M | 0.63% | 58 |
|
|
2015
Q2 | $5.34M | Buy |
60,765
+6,765
| +13% | +$595K | 0.64% | 53 |
|
|
2015
Q1 | $4.01M | Sell |
54,000
-31,398
| -37% | -$2.33M | 0.68% | 50 |
|
|
2014
Q4 | $4.78M | Buy |
85,398
+28,398
| +50% | +$1.59M | 1.39% | 23 |
|
|
2014
Q3 | $2.59M | Sell |
57,000
-33,000
| -37% | -$1.5M | 0.76% | 47 |
|
|
2014
Q2 | $3.73M | Buy |
+90,000
| New | +$3.73M | 1.11% | 29 |
|